Explore Our Comprehensive Life Sciences Industry Research Reports
P
2019
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
P
2019
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
P
2020
The North America liver disease treatment market accounted for $6,970 million in 2019, and is expected to reach $8,318 million by 2027, registering a CAGR of 5.2% from 2020 to 2027.
Report Code : A07181 | Pages : 137 | Category : Life Sciences
P
2023
Research study titled U.S. Epilepsy Drugs Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.
Report Code : A105922 | Pages : 77 | Category : Life Sciences
P
2023
Leading players in Canada Epilepsy Drugs Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.
Report Code : A105923 | Pages : 77 | Category : Life Sciences
P
2023
The Mexico Epilepsy Drugs Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.
Report Code : A105924 | Pages : 77 | Category : Life Sciences
P
2023
Distribution Channel is projected as the most lucrative segment. The report provides insights based on the key determinants of the market, including drivers and challenges along with their relative impact on the regional and country level.
Report Code : A105925 | Pages : 122 | Category : Life Sciences
P
2023
Distribution Channel segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Germany Epilepsy Drugs Market due to the outbreak of COVID-19.
Report Code : A105926 | Pages : 79 | Category : Life Sciences
P
2023
The France Epilepsy Drugs Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.
Report Code : A105927 | Pages : 75 | Category : Life Sciences
P
2023
In market Distribution Channel, Drug Stores and Retail Pharmacies holds the largest revenue share during the analysis period and Distribution Channel is expected to exhibit the highest CAGR over the analysis period.
Report Code : A105928 | Pages : 84 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.